Early research (Phase 1)Ended earlyNCT05069935What this trial is testingFT538 in Combination With Monoclonal Antibodies in Advanced Solid TumorsWho this might be right forSolid Tumor, Adult Fate Therapeutics 16
Testing effectiveness (Phase 2)Study completedNCT03660449What this trial is testingModerately Hypofractionated Conformal Radiation Combined With S-1 for Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma Sun Yat-sen University 58
Early research (Phase 1)Ended earlyNCT06034860What this trial is testingStudy of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer TypesWho this might be right forNon Small Cell Lung CancerHepatocellular CarcinomaMelanoma+8 more Molecular Templates, Inc. 15
Testing effectiveness (Phase 2)UnknownNCT04888403What this trial is testingExploring the Safety and Effectiveness of Toripalimab Combined With Neoadjuvant Radiotherapy and Chemotherapy in the Locally Advanced Esophageal Squamous Cell CarcinomaWho this might be right forLocally Advanced Esophageal Squamous Cell Carcinoma The First Affiliated Hospital of Zhengzhou University 45
Large-scale testing (Phase 3)Not Yet RecruitingNCT07251062What this trial is testingSYS6010, Enlonstobart, and Chemotherapy for First-Line Treatment of Esophageal Squamous Cell Carcinoma.Who this might be right forEsophageal Squamous Cell Carcinoma CSPC Megalith Biopharmaceutical Co.,Ltd. 737
Testing effectiveness (Phase 2)Study completedNCT02350517What this trial is testingEndostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal CancerWho this might be right forEsophageal Squamous Cell Carcinoma Yuhong Li 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013What this trial is testingNivolumab and Ipilimumab in Treating Patients With Rare TumorsWho this might be right forAcinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more National Cancer Institute (NCI) 798
Testing effectiveness (Phase 2)UnknownNCT05636150What this trial is testingA Phase II Clinical Study of Fruquintinib Combined With S-1 for Advanced Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma Peking Union Medical College Hospital 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT07682376What this trial is testingLow-Dose Radiotherapy With Retlirafusp Alfa and Chemotherapy as Neoadjuvant Therapy for Resectable Locally Advanced Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma (ESCC) Harbin Medical University 96
Large-scale testing (Phase 3)Study completedNCT00002897What this trial is testingSurgery With or Without Chemotherapy in Treating Patients With Stage II or Stage III Cancer of the EsophagusWho this might be right forEsophageal Cancer European Institute of Oncology 240
Early research (Phase 1)Study completedNCT00030498What this trial is testingErlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more National Cancer Institute (NCI) 75
Large-scale testing (Phase 3)UnknownNCT05737563What this trial is testingPD-1 Antibody Combined With mXELIRI Versus mXELIRI in the Second-line Setting for ESCCWho this might be right forEsophageal Squamous Cell Carcinoma Abdominal Stage 0 Sun Yat-sen University 380
Large-scale testing (Phase 3)Looking for participantsNCT06138028What this trial is testingSintilimab and Chemotherapy Sequential Radiotherapy in Advanced Esophageal CancerWho this might be right forMetastatic Esophageal Squamous Cell Carcinoma Qingdao Central Hospital 90
Testing effectiveness (Phase 2)UnknownNCT05833971What this trial is testingCadonilimab in Combination With Chemotherapy for Locally Advaced Esophageal Squamous Cell CarcinomaWho this might be right forResectable Esophageal Squamous Cell CarcinomaNeoadjuvant Therapy Guangzhou Institute of Respiratory Disease 43
Testing effectiveness (Phase 2)Ended earlyNCT00006472What this trial is testingCombination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal CancerWho this might be right forEsophageal Cancer Medstar Health Research Institute 4
Early research (Phase 1)Not Yet RecruitingNCT07807345What this trial is testingPhase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or MetastaticWho this might be right forHead & Neck Squamous Cell CarcinomaNon-Small Cell Lung CancerEsophageal Cancer+5 more Sutro Biopharma, Inc. 285
Not applicableNot Yet RecruitingNCT07822906What this trial is testingRisk of Esophageal Cancer Returning After Immunotherapy, Chemotherapy, and SurgeryWho this might be right forEsophageal Squamous Cell Carcinoma (ESCC) Peking University Cancer Hospital & Institute 100
Testing effectiveness (Phase 2)Looking for participantsNCT07638436What this trial is testingAdebrelimab Combined With Neoadjuvant Chemotherapy in Borderline Resectable Locally Advanced Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma (ESCC) Sun Yat-sen University 42
Early research (Phase 1)Ended earlyNCT04244552What this trial is testingA Phase 1b Trial of ATRC-101 in Adults With Advanced Solid MalignanciesWho this might be right forBreast CancerColorectal CancerOvarian Cancer+13 more Atreca, Inc. 87
Large-scale testing (Phase 3)Study completedNCT06775652What this trial is testingNeoadjuvant Chemoradiotherapy Plus Surgery vs. Surgery Plus Adjuvant Therapy for ESCCWho this might be right forEsophageal Squamous Cell Carcinoma (ESCC) Yongtao Han 254